The times they are a changing, as evidenced by this January 10 and 11 workshop sponsored by NAS:  The Promise of Genome Editing Tools to...

Agent Orange. Two words that drove massive litigation and helped to drive increased scientific research, including the Human Genome...

A recent article explains that mesotheliomas in South Korea are projected to increase over the years ahead, mainly because of...

The molecular revolution continues, with continuing implications for improving our understanding of how external events effect our cells....

From the Manville bankruptcy circa 2002,  some interesting briefs from lawyers representing persons with cancer. In general terms, the...

In the good old days, there was more asbestos trust transparency as to overall statistics for the Manville Trust. One reason for the...

Suppose your next jury trial involves issues about cancer. Will you be able to use AI and big data – during jury selection – to quickly...

Researchers continue to identify more and more genes that appear relevant to development of mesothelioma. Are you experts and trial team...

Imagine all the data, hypotheses and conclusions that will emerge from sequencing 500k biobanked leukemia and lymphoma tumors … Imagine...

In the shameless self-promotion department, another article on “omics” and torts. LAW360 kindly published this on February 21, 2017.  In...

Image of World Cancer Day 2017 It is World Cancer Day 2017. The many diseases we call “cancer” will kill tens of millions over the coming...

The following is a guest post by Paul A. Bradley of Maron Marvel Bradley Anderson & Tardy LLC. A decision from Delaware Superior Court...

The first genome cost $3-4 billion, and took over a decade; one can debate the specifics.  Times change. Last week, the world leader in...

How does/can a product “cause” an undesired outcome in the formation of limbs or diseases such as cancer, and how can/does one test to...

One year ago, Illumina announced a stunning goal: find all cancers very early (stage 1 or 2) through use of massive computing power and...

Mealey’s recently highlighted the latest example of financiers and entrepreneurial claiming creating change in the asbestos litigation...

It’s not been a good run of days for asbestos defendants and other current and former sellers of alleged toxins. Yesterday,  under the...

A projected 18% increase in insurance company asbestos losses was announced yesterday by A.M. Best. Some of us are not surprised. Indeed,...

2016 has not been a good year for defendants in asbestos cases. The point has been illustrated several times. A prime example is the...

Science, law and mass torts are increasingly intersecting and driving change.  The cancer research and medical communities are currently...